You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PCYC

Showing 1 - 25 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Post-Chlorambucil Therapy Follow-up
  • +4 more
  • Duarte, California
  • +106 more
Aug 6, 2021

Chronic GVHD Trial in Worldwide (Ibrutinib)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Duarte, California
  • +47 more
Jul 15, 2022

Diffuse Large B-cell Lymphoma(DLBCL) Trial in Shanghai (Zanubrutinib + R-CHOP)

Recruiting
  • Diffuse Large B-cell Lymphoma(DLBCL)
  • Zanubrutinib + R-CHOP
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 10, 2022

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Lymphoma, B-Cell
  • +4 more
  • Burbank, California
  • +90 more
Mar 31, 2022

Follicular Lymphoma, Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2 Trial in United States (Ibrutinib)

Terminated
  • Follicular Lymphoma
  • +3 more
  • Basking Ridge, New Jersey
  • +8 more
Jun 21, 2019

Ibrutinib Combined With Bendamustine and Rituximab in Newly

Recruiting
  • Mantle Cell Lymphoma (MCL)
    • Beijing, Beijing, China
      Peking University Third Hospital
    May 31, 2022

    Mantle-Cell Lymphoma Trial in Worldwide (Ibrutinib, Venetoclax, Placebo Oral tablet to match Venetoclax)

    Active, not recruiting
    • Mantle-Cell Lymphoma
    • Tucson, Arizona
    • +119 more
    Dec 29, 2021

    Mantle Cell Lymphoma Trial in Beijing

    Recruiting
    • Mantle Cell Lymphoma
      • Beijing, Beijing, China
        Hongmei Third Jing
      Jun 20, 2022

      Chronic GVHD Trial in Worldwide (ibrutinib, Placebo, Prednisone)

      Completed
      Has Results
      • Chronic Graft Versus Host Disease
      • Scottsdale, Arizona
      • +101 more
      Jan 24, 2022

      Follicular Lymphoma Trial in Worldwide (ibrutinib, to match ibrutinib, rituximab)

      Active, not recruiting
      • Follicular Lymphoma
      • Mobile, Alabama
      • +168 more
      Oct 6, 2021

      Waldenström's Macroglobulinemia Trial in Worldwide (Ibrutinib, Placebo, Rituximab)

      Completed
      Has Results
      • Waldenström's Macroglobulinemia
      • Los Angeles, California
      • +47 more
      Feb 9, 2021

      B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

      Completed
      Has Results
      • B-cell Chronic Lymphocytic Leukemia
      • +9 more
      • Stanford, California
      • +15 more
      May 14, 2020

      Multiple Myeloma Trial in Canada, United States (Ibrutinib, Carfilzomib, Dexamethasone)

      Completed
      Has Results
      • Multiple Myeloma
      • Duarte, California
      • +16 more
      Nov 24, 2021

      Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (Ibrutinib, Gemcitabine, Nab-paclitaxel)

      Completed
      Has Results
      • Metastatic Pancreatic Adenocarcinoma
      • Huntsville, Alabama
      • +85 more
      Dec 7, 2020

      Multiple Myeloma Trial in Worldwide (Ibrutinib, Bortezomib, Dexamethasone)

      Completed
      Has Results
      • Multiple Myeloma
      • Brno, Czechia
      • +32 more
      Mar 2, 2020

      Marginal Zone Lymphoma, B-cell Lymphoma Trial in Worldwide (ibrutinib)

      Completed
      Has Results
      • Marginal Zone Lymphoma
      • B-cell Lymphoma
      • Tucson, Arizona
      • +24 more
      Oct 8, 2019

      Multiple Myeloma Trial in Worldwide (Ibrutinib, Pomalidomide, Dexamethasone)

      Terminated
      Has Results
      • Multiple Myeloma
      • Duarte, California
      • +15 more
      Nov 4, 2019

      GVHD Trial in United States (Ibrutinib)

      Completed
      Has Results
      • Graft Versus Host Disease
      • Duarte, California
      • +9 more
      Jun 14, 2019

      Breast Cancer, Chronic Myeloproliferative Disorders, Colorectal Cancer Trial in Pittsburgh, Madison (doxorubicin HCl, motexafin

      Completed
      • Breast Cancer
      • +11 more
      • doxorubicin hydrochloride
      • motexafin gadolinium
      • Pittsburgh, Pennsylvania
      • +1 more
      Dec 12, 2019

      Chronic Lymphocytic Leukemia, Small-Cell Lymphoma Trial in Worldwide (Ibrutinib, Obinutuzumab, Chlorambucil)

      Completed
      Has Results
      • Chronic Lymphocytic Leukemia
      • Small-Cell Lymphoma
      • La Jolla, California
      • +70 more
      Aug 27, 2020

      Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ofatumumab, ibrutinib)

      Completed
      Has Results
      • Relapsed or Refractory Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • La Jolla, California
      • +75 more
      Dec 3, 2019

      Follicular Lymphoma, B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (Ibrutinib, rituximab)

      Completed
      Has Results
      • Follicular Lymphoma
      • +2 more
      • Burbank, California
      • +11 more
      Mar 26, 2019

      NSCLC, Breast Cancer, Pancreatic Cancer Trial in United States (Ibrutinib, Durvalumab)

      Completed
      Has Results
      • Non-Small Cell Lung Cancer
      • +2 more
      • Birmingham, Alabama
      • +16 more
      Dec 7, 2018

      DLBCL, Follicular Lymphoma Trial in United States (Ibrutinib, MEDI4736)

      Completed
      Has Results
      • Diffuse Large B-Cell Lymphoma
      • Follicular Lymphoma
      • Birmingham, Alabama
      • +10 more
      Jun 3, 2019

      Relapsed DLBCL, Refractory DLBCL Trial in Worldwide (Ibrutinib, Lenalidomide, Rituximab)

      Completed
      Has Results
      • Relapsed Diffuse Large B-Cell Lymphoma
      • Refractory Diffuse Large B-Cell Lymphoma
      • Birmingham, Alabama
      • +39 more
      Jan 6, 2022